Navigation Links
AEterna Zentaris Closes Sale of Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners
Date:12/3/2008

l under management. The firm invests principally in commercial-stage biopharmaceutical and medical device companies and products, through the purchase of royalty or Synthetic Royalty(SM) interests, debt and equity. CHRP's investment team has over 90 years of healthcare related experience including principal investing, structured finance, healthcare industry senior management, Wall Street research and consulting, scientific and clinical experience. For more information, please visit www.cowenroyalty.com.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology, with proven expertise in drug discovery, development and commercialization.

News releases and additional information are available at www.aezsinc.com.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of the Company to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these fo
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... , HOUSTON, Dec. 3 Jou...has updated its facility to offer patients a secon...along with the LAP-BAND® System that it cur...edure at the facility was performed by surgeon par...9. The patient is reported as doing well. ,, Th...
(Date:12/3/2009)... , PHILADELPHIA, Dec. 3 /PRNewswire-FirstCa...global specialty biopharmaceutical company, today ...ntary market withdrawal of one lot of the Attentio...rana ® . Shire is taking this action because ... may not meet their release liner removal specific...
(Date:12/3/2009)... , NEW DELHI, India, Dec. 3 /PRN...ef Science Officer at Shenzhen Beike Biotechnology...at a conference on High-Risk Diabetic,Foot Care in...na,s leading,stem cell research and regenerative m...zed by the Indian Podiatry Association (IPA), aime...
(Date:12/2/2009)... , NEW YORK, Dec. 2 R...ch report is available in its catalogue: ,, Ca...ve ,, http://www.reportlinker.com/p0164368/Ca...ve.html ,, Incubators are the most critical e...esearch, and other applications for providing a co...
Breaking Biology Technology:JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
... $14.1 million--, XI,AN, China, Oct. 16 /Xinhua-P...(OTC Bulletin Board: CBEH) ("China Bio Energy" and...istribution of heavy oil and finished oil,products... fuel, announced,that it has completed a $9,000,00...nture that is convertible into 2,465,753 shares of...
...chnology Implant Offers Promising Patient Solution...chnology,Inc., a leader in innovative medical devi...tion of its new biologic inter-body spacer. The,na...lly robust,nano-crystalline hydroxyapatite (HA) an...ere performed at hospitals in Beijing and Suzhou, ...
... A team of researchers from,Intrinsic Bioprobes In...rometry immunoassay for the detection of bioactive...ublished online on Oct. 14 in the journal of,Circu...agues from Scios,Inc. in Fremont, Christ Hospital ...o, the team discovered very low concentration of b...
Other Biology Technology:China Bio Energy Holdings Group Announces Financing and Exercise of Warrants 2China Bio Energy Holdings Group Announces Financing and Exercise of Warrants 3Pioneer(R) Surgical Technology Announces First Human Implants of New nanOss(TM)-Cervical Fusion Device 2Novel Mass Spectrometry-based Assay Reveals Degradation and Low Levels of Bioactive B-type Natriuretic Peptide (BNP) in Patients with Heart Failure 2
(Date:12/2/2009)... first cigarette within minutes after waking up ha... nicotine when processed by the body, than those w...rettes smoked. , "Since cotinine levels appea...suggest that smokers who smoke immediately after w...said researcher Joshua E. Muscat, Ph.D., M.P.H., p...
(Date:12/2/2009)... status did not prompt people participating in a l...screening program to pick up their cigarettes agai...er Epidemiology, Biomarkers & Prevention , a journ.... The December issue contains a special focus on t...d concern in the lung screening community that rea...
(Date:12/2/2009)...rgia College of Veterinary Medicine have made an "...nues for treating Ichthyophthirius multifiliis, or...site that commonly attacks freshwater fish. , Wi... found that Ich harbors two apparently symbiotic i...ally found free-living, and Rickettsia, which are ...
Breaking Biology News(10 mins):Increased nicotine levels detected in those who light-up earlier 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 3US Farms Inc Announces Broker Network Agreement With Sunshine Specialties for Aloe365 Products 58160 1US Farms Inc Announces Broker Network Agreement With Sunshine Specialties for Aloe365 Products 58160 2US Farms Inc Announces Broker Network Agreement With Sunshine Specialties for Aloe365 Products 58160 3Pelosi Remarks at the Congressional Black Caucus Foundations Annual Legislative Conference 58156 1Pelosi Remarks at the Congressional Black Caucus Foundations Annual Legislative Conference 58156 2Pelosi Remarks at the Congressional Black Caucus Foundations Annual Legislative Conference 58156 3Food Addicts Convention Draws 800 Members from 31 States 5 Nations Around the World 58152 1Food Addicts Convention Draws 800 Members from 31 States 5 Nations Around the World 58152 2Food Addicts Convention Draws 800 Members from 31 States 5 Nations Around the World 58152 3
... A potentially fatal species of malaria is being ... disease, thereby putting lives at risk, according...University Malaysia Sarawak. , Researchers in M...ia patients across the country. Using DNA-based te...ients in Sarawak, Malaysian Borneo, were infected ...
... CAMBRIDGE, Mass. - MIT and Italian energy compan...nership. The centerpiece of this collaboration wil...nced solar technologies, from novel photovoltaic m...Eni will also become a Founding Member of the MIT ...of diverse energy research projects at the Institu...
...OSEN, Ill., Jan. 14 Corporate Safe Specialists (C...n. The Company has hired,Larry M. Ladd as National...m/cgi-bin/prnh/20080114/AQM106 ), (Logo: http://..., James Currey, Sales Manager of the Company, sta... further accelerate the growth we,ve seen in,netwo...
Other Biology News:Monkey malaria widespread in humans and potentially fatal 2MIT, Eni announce energy research partnership 2MIT, Eni announce energy research partnership 3Corporate Safe Specialists Announces Addition to Sales Team 2
McCown's Woody Plant Basal Salt Mixture from Sigma-Aldrich
...ing Kit is a very sensitive immunohistochemical to..., containing both anti-von Willebrand Factor and a... variety of species. This AP kit provides a simple... paraffin-embedded sections in human (both CD31 an...
Qproteome Nuclear Subfractionation Kit from QIAGEN
Nutrient Mixture F-12 Ham, Coon's Modification (Ham's F-12 Coon's) from Sigma-Aldrich
Biology Products: